Clinical Trials · NCT01973231
Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 404
- Start date
- Oct 2013
- Locations
- 61 sites, 9 countries
- Primary endpoint
- Change in Glycosylated Haemoglobin (HbA1c) From Baseline